For the quarter ending September 30, 2025, Dr. Reddy’s Laboratories reported revenues of U.S.$1,954 million and a profit of U.S.$319 million. This filing highlights their financial performance with total assets at U.S.$6,105 million and total liabilities at U.S.$2,027 million.